These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32032523)

  • 1. Human iPSCs Stretch to Improve Tissue-Engineered Vascular Grafts.
    Abutaleb NO; Truskey GA
    Cell Stem Cell; 2020 Feb; 26(2):136-137. PubMed ID: 32032523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-Engineered Vascular Grafts with Advanced Mechanical Strength from Human iPSCs.
    Luo J; Qin L; Zhao L; Gui L; Ellis MW; Huang Y; Kural MH; Clark JA; Ono S; Wang J; Yuan Y; Zhang SM; Cong X; Li G; Riaz M; Lopez C; Hotta A; Campbell S; Tellides G; Dardik A; Niklason LE; Qyang Y
    Cell Stem Cell; 2020 Feb; 26(2):251-261.e8. PubMed ID: 31956039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous endothelialized small-caliber vascular grafts engineered from blood-derived induced pluripotent stem cells.
    Generali M; Casanova EA; Kehl D; Wanner D; Hoerstrup SP; Cinelli P; Weber B
    Acta Biomater; 2019 Oct; 97():333-343. PubMed ID: 31344511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-Caliber Tissue-Engineered Vascular Grafts Based on Human-Induced Pluripotent Stem Cells: Progress and Challenges.
    Ji J; Xu H; Li C; Luo J
    Tissue Eng Part B Rev; 2023 Aug; 29(4):441-455. PubMed ID: 36884294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods for Differentiating hiPSCs into Vascular Smooth Muscle Cells.
    Li ML; Luo J; Ellis MW; Riaz M; Ajaj Y; Qyang Y
    Methods Mol Biol; 2022; 2375():21-34. PubMed ID: 34591296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Progress in Vascular Engineering and Its Clinical Applications.
    Jouda H; Larrea Murillo L; Wang T
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human iPS Cell-derived Tissue Engineered Vascular Graft: Recent Advances and Future Directions.
    Shi X; He L; Zhang SM; Luo J
    Stem Cell Rev Rep; 2021 Jun; 17(3):862-877. PubMed ID: 33230612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient Differentiation of Human Induced Pluripotent Stem Cells into Endothelial Cells under Xenogeneic-free Conditions for Vascular Tissue Engineering.
    Luo J; Shi X; Lin Y; Yuan Y; Kural MH; Wang J; Ellis MW; Anderson CW; Zhang SM; Riaz M; Niklason LE; Qyang Y
    Acta Biomater; 2021 Jan; 119():184-196. PubMed ID: 33166710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xenogeneic-free generation of vascular smooth muscle cells from human induced pluripotent stem cells for vascular tissue engineering.
    Luo J; Lin Y; Shi X; Li G; Kural MH; Anderson CW; Ellis MW; Riaz M; Tellides G; Niklason LE; Qyang Y
    Acta Biomater; 2021 Jan; 119():155-168. PubMed ID: 33130306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue-engineered vascular grafts created from human induced pluripotent stem cells.
    Sundaram S; One J; Siewert J; Teodosescu S; Zhao L; Dimitrievska S; Qian H; Huang AH; Niklason L
    Stem Cells Transl Med; 2014 Dec; 3(12):1535-43. PubMed ID: 25378654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue engineered small-diameter vascular grafts.
    Schmedlen RH; Elbjeirami WM; Gobin AS; West JL
    Clin Plast Surg; 2003 Oct; 30(4):507-17. PubMed ID: 14621299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable tissue-engineered blood vessels from human induced pluripotent stem cells.
    Gui L; Dash BC; Luo J; Qin L; Zhao L; Yamamoto K; Hashimoto T; Wu H; Dardik A; Tellides G; Niklason LE; Qyang Y
    Biomaterials; 2016 Sep; 102():120-9. PubMed ID: 27336184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fabrication of tissue-engineered vascular grafts with stem cells and stem cell-derived vascular cells.
    Wang L; Hu J; Sorek CE; Chen EY; Ma PX; Yang B
    Expert Opin Biol Ther; 2016; 16(3):317-30. PubMed ID: 26560995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Human Induced Pluripotent Stem Cells in Generating Tissue-Engineered Blood Vessels as Vascular Grafts.
    Cong X; Zhang SM; Batty L; Luo J
    Stem Cells Dev; 2019 Dec; 28(24):1581-1594. PubMed ID: 31663439
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Keshavarzian M; Meyer CA; Hayenga HN
    Tissue Eng Part C Methods; 2019 Nov; 25(11):641-654. PubMed ID: 31392930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced elastin synthesis and maturation in human vascular smooth muscle tissue derived from induced-pluripotent stem cells.
    Eoh JH; Shen N; Burke JA; Hinderer S; Xia Z; Schenke-Layland K; Gerecht S
    Acta Biomater; 2017 Apr; 52():49-59. PubMed ID: 28163239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Readily Available Tissue-Engineered Vascular Grafts Derived From Human Induced Pluripotent Stem Cells.
    Luo J; Qin L; Park J; Kural MH; Huang Y; Shi X; Riaz M; Wang J; Ellis MW; Anderson CW; Yuan Y; Ren Y; Yoder MC; Tellides G; Niklason LE; Qyang Y
    Circ Res; 2022 Mar; 130(6):925-927. PubMed ID: 35189711
    [No Abstract]   [Full Text] [Related]  

  • 18. The Current Status of Tissue-Engineered Vascular Grafts.
    Jaspan VN; Hines GL
    Cardiol Rev; 2015; 23(5):236-9. PubMed ID: 25699981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular diseases await translation of blood vessels engineered from stem cells.
    Samuel R; Duda DG; Fukumura D; Jain RK
    Sci Transl Med; 2015 Oct; 7(309):309rv6. PubMed ID: 26468328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue engineering vascular grafts a fortiori: looking back and going forward.
    G N; Tan A; Gundogan B; Farhatnia Y; Nayyer L; Mahdibeiraghdar S; Rajadas J; De Coppi P; Davies AH; Seifalian AM
    Expert Opin Biol Ther; 2015 Feb; 15(2):231-44. PubMed ID: 25427995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.